Tirzepatide

Description

Tirzepatide represents a advanced research peptide due to its dual agonist activity at both the Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. This dual-action mechanism is a key focus of metabolic research, as it may influence insulin sensitivity, lipid metabolism, and adiposity through multiple pathways. Its research profile makes it a compound of high interest for studies on hormonal signaling cascades related to weight management and glucose regulation in laboratory settings.